Providing one global lab partner to support your oncology research from discovery to post-market.
Q2 Solutions’ scientific experts integrate therapeutic insights, state-of-the-art technologies, best-in-class methods and quality systems to optimize your anti-infective or vaccine study design, ensuring high-quality data delivery and regulatory approval.
With emerging and re-emerging infectious diseases the development of new anti-infectives and vaccines presents many challenges. We understand these challenges and our scientific experts can provide you with the strategic guidance to develop and validate custom assays and provide you with the high-quality laboratory services you need to ensure regulatory success.
Tailored solutions for your most complex challenges
As increasing regulatory and scientific complexities threaten R&D productivity, you need a partner with scientific competence, regulatory expertise and capacity to meet demanding timelines via tailored solutions.
Broad testing and reporting capabilities for improved tuberculosis (TB) and HIV screening programs in South Africa.
Q2 Solutions’ unique global flow cytometry services implemented with customizable solutions are designed to meet your clinical trial needs.
Q2 Solutions’ comprehensive in-house end-to-end anatomic pathology and adjunct molecular services are designed to meet your clinical trial needs.
Deeper science to drive tailored solutions, optimized quality systems, delivery excellence and better insights.
Deeper science to drive tailored solutions, optimized quality systems, delivery excellence and better insights.
Genomic Know-How® to drive tailored solutions, optimized quality systems, delivery excellence and better insights.
|
|
|
|
|
|
|
|
|